[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
February 16, 1957


JAMA. 1957;163(7):551-552. doi:10.1001/jama.1957.02970420033012

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


Legal requirements for premarital and prenatal serologic blood testing should not be rescinded until all the many questions for and against such legislation have been answered by a sound epidemiologic study, according to a panel of eminent dermatologists and public health representatives.

Dr. Charles R. Rein, chairman of this special symposium at the recent meeting of the American Academy of Dermatology and Syphilology, called the panel "an unofficial expert committee to evaluate the medical and economic value of this existing legislation." All but seven states now have some form of compulsory blood-testing program. In discussing all aspects of the subject, Dr. Rein mentioned the New York state study of 1954, which indicated the cost per infectious case discovered to be about $30,000. This same study showed that only one new infectious case of syphilis was found per 10,000 persons examined. In contrast, Dr. Rein then referred to the increasing cases

First Page Preview View Large
First page PDF preview
First page PDF preview